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Abstract
Background: Body mass index (BMI) will be a reportable health measure in the United States (US)
through implementation of Healthcare Effectiveness Data and Information Set (HEDIS) guidelines.
We evaluated current documentation of BMI, and documentation and control of associated risk
factors by BMI category, based on electronic health records from a 12-clinic primary care network.
Methods: We conducted a cross-sectional analysis of 79,947 active network patients greater than
18 years of age seen between 7/05 - 12/06. We defined BMI category as normal weight (NW, 18-
24.9 kg/m2), overweight (OW, 25-29.9), and obese (OB, ≥ 30). We measured documentation (yes/
no) and control (above/below) of the following three risk factors: blood pressure (BP) ≤130/≤85
mmHg, low-density lipoprotein (LDL) ≤130 mg/dL (3.367 mmol/L), and fasting glucose <100 mg/dL
(5.55 mmol/L) or casual glucose <200 mg/dL (11.1 mmol/L).
Results: BMI was documented in 48,376 patients (61%, range 34-94%), distributed as 30% OB, 34%
OW, and 36% NW. Documentation of all three risk factors was higher in obesity (OB = 58%, OW
= 54%, NW = 41%, p for trend <0.0001), but control of all three was lower (OB = 44%, OW =
49%, NW = 62%, p = 0.0001). The presence of cardiovascular disease (CVD) or diabetes modified
some associations with obesity, and OB patients with CVD or diabetes had low rates of control of
all three risk factors (CVD: OB = 49%, OW = 50%, NW = 56%; diabetes: OB = 42%, OW = 47%,
NW = 48%, p < 0.0001 for adiposity-CVD or diabetes interaction).
Conclusions: In a large primary care network BMI documentation has been incomplete and for
patients with BMI measured, risk factor control has been poorer in obese patients compared with
NW, even in those with obesity and CVD or diabetes. Better knowledge of BMI could provide an
opportunity for improved quality in obesity care.
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Background
Obesity is a common problem in the United States that
independently confers risk for chronic disease and early
mortality [1]. Several studies address the importance of
recognition and treatment of obesity in chronic disease
management, but few evaluate body mass index (BMI)
assessment and risk factor documentation and control in
patients who are obese both with and without cardiovas-
cular disease (CVD), diabetes or risk factors [2-6].
Assessments of BMI and CVD or diabetes risk factors are
simple, inexpensive tools that can be used by primary care
physicians (PCPs) to address obesity and its complica-
tions. Little consensus exists in current guidelines con-
cerning the need to screen for BMI and associated risk
factors [7-15]. In 1998 the National Heart, Lung, and
Blood Institute (NHLBI) established guidelines for BMI
and risk factor measurement in all patients under 80 years
of age with the goal of implementation of strategies for
weight loss and risk factor control in patients with a BMI
of ≥ 30 kg/m2 or 25-29.9 kg/m2 and ≥ two risk factors [10].
In 2007 the National Committee for Quality Assurance
(NCQA) organized field tests of a prospective Healthcare
Effectiveness Data and Information Set (HEDIS) measure
to assess the percentage of members 18-74 years of age
with an outpatient visit, and who had BMI documented
and risk factors documented if found to have a BMI of ≥30
kg/m2 [16]. Their work led to the proposed HEDIS 2009
measure  BMI Assessment [17], which is proposed for
reporting by commercial, Medicaid, and Medicare plans.
Given the magnitude and clinical impact of the current
obesity epidemic and its risk factors, and the potential
implementation of the HEDIS BMI Assessment measure,
we aimed to examine current care in BMI and risk factor
assessment for patients in a large network of primary care
practices that use a common electronic health record
(EHR). We investigated the prevalence of BMI measure-
ment and documentation and control of the CVD and dia-
betes risk factors blood pressure (BP), low density
lipoprotein (LDL), and fasting and casual glucose. We
examined these risk factors according to the BMI catego-
ries normal weight, overweight, and obese. We hypothe-
sized that documentation of BMI would vary widely in
clinical practice, and that patients who were obese would
be more likely to have better documentation, but poorer
control, of risk factors than patients of normal weight.
Methods
Setting and Patients
We identified 138,933 patients in our primary care
research network of twelve practices that make up the
Massachusetts General Hospital Primary Care Practice
Based Research Network (PBRN). Practices include urban
academic faculty practices, private offices, and commu-
nity health centers in and around Boston, Massachusetts.
These twelve practices use a common EHR that contains
all clinical and utilization data for each patient. The data
from the EHR data are searchable in the Research Patient
Data Repository (RPDR) [18]. From these, we included
79,947 patients who were at least 18 years of age and had
at least two clinic visits billed to their PCP between 7/1/05
and 12/31/06, and did not have a height greater than or
equal to seven feet (2.13 meters), weight <70 or >1000
pounds (<31.8 or >453.6 kilograms), systolic BP <50 or
>260 mmHg, or diastolic BP <30 or >150 mmHg. The
study was approved by the Partners Health Care System
Institutional Review Board.
BMI Measurement
The intent of the HEDIS initiative is to measure and
increase documentation of BMI. We obtained BMI from
height and weight data recorded in the EHR, where they
are used to automatically calculate and display BMI. For
this analysis we calculated BMI from the most recent
weight in the 18-month period and the most recent height
prior to 12/31/06 from structured coded entries in the
EHR. For completeness, we also searched the text of narra-
tive notes in the EHR using a validated Natural Language
Processing abstraction tool that computationally abstracts
weight, height, and BP values from the free text of clini-
cian notes [19,20]. The sensitivity and specificity of the
approach to abstraction (compared with a trained chart
abstractor) are 87.9% and 99% for detection of height,
91.8% and 92.1% for detection of weight, and 91% and
96% for detection of BP [19,20]. Because of high rates of
missing heights, we confirmed with clinic site medical
directors that we had searched in all the appropriate
places in the clincial record for height and weight infor-
mation.
We categorized BMI using Centers for Disease Control
(CDC) definitions, with underweight equal to BMI <18.5
kg/m2, normal weight equal to a BMI of 18.5-<25 kg/m2,
overweight BMI equal to 25-<30 kg/m2, and obese BMI
≤30 kg/m2 [21]. We included underweight patients when
measuring documentation of BMI, but excluded them
otherwise. Among those with a documented BMI, we
examined documentation and control of three risk fac-
tors: blood pressure (BP), LDL cholesterol, and fasting or
casual glucose levels, or both. We examined risk factor
documentation and control in the clinic population over-
all, and stratified by three BMI categories.
Risk Factor, CVD, and Diabetes Measurement
Documentation of a risk factor was defined as being
found in the EHR at least once within the study period. If
a risk factor was documented more than once, we used the
most recently documented value. A risk factor was defined
as controlled if within normal range, defined as: BP ≤130/BMC Health Services Research 2009, 9:236 http://www.biomedcentral.com/1472-6963/9/236
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≤85 mmHg, LDL<130 mg/dL (3.367 mmol/L), and fast-
ing glucose <100 mg/dL (5.55 mmol/L) or casual glucose
<200 mg/dL (11.1 mmol/L) [22-24]. We also measured
documentation and control of all three risk factors com-
bined as an aggregate measure of risk factor management.
We defined clinical CVD as coronary artery disease, cere-
brovascular accident, or peripheral vascular disease listed
on the EHR Problem List, or as having two outpatient or
one inpatient International Classification of Diseases,
Ninth Revision (ICD-9) codes for CVD. We defined clini-
cal diabetes as diabetes on the EHR problem list and a dia-
betes medication on the medication list, or as having two
outpatient or one inpatient codes related to diabetes. The
definitions of diabetes, hypertension, hyperlipidemia and
CVD have previously been validated [25,26]. For instance,
the sensitivity of our approach for diabetes or CVD are
>98% and specificity of >97% compared to the gold
standard of trained research nurse chart abstraction. We
used the same approach as for diabetes to define hyper-
tension and hyperlipidemia. Other measurements
included age, race, gender, number of PCP visits during
the study period, insurance type, and clinic site.
Statistical Analysis
We conducted a cross-sectional analysis. We measured
rates of BMI documentation in each clinic site and overall.
Among those with a BMI, we measured risk factor docu-
mentation and control overall, and stratified by the three
BMI categories. We further stratified the analysis by the
presence or absence of CVD or diabetes. We used general-
ized linear models or chi-square tests to test levels or rates
of characteristics by BMI category. We used the Breslow
Day test for homogeneity of odds ratios to test for effect
modification of CVD or diabetes on the association of
BMI with risk factor documentation and control. We used
SAS version 9.1 (Cary, NC) for all analyses, and consid-
ered a p value of <0.05 to indicate statistical significance.
Results
BMI Documentation and Characteristics of Patients with 
Documented BMI
Of 79,947 patients, 72,633 (90.9%) had an available
weight, 50,345 (63.0%) had an available height, and
48,376 (60.5%) had both height and weight recorded to
calculate BMI (Table 1). Of those with BMI present,
14,290 patients (30%) were classified as obese, 16,402
(34%) overweight, 16,936 (36%) normal weight, and 748
(2%) underweight. Compared to those missing BMI,
patients with BMI documented were younger, had a
higher mean number of PCP visits, were more likely to be
women, and were more likely to have commercial insur-
ance or Medicare than patients without a BMI (p < 0.0001
for all; Table 2). As expected, patients with obesity were
older, less likely to be women, white, or to have private
insurance or Medicare, had a higher mean number of PCP
visits, and were more likely to have a history of CVD, dia-
betes, hypertension, and dyslipidemia than patients of
normal weight (p < 0.0001 for all; Table 3).
Documentation and Control of Risk Factors
Overall, less than 78% had at least one risk factor docu-
mented and just half had all three documented (Table 4,
Figure 1). Of these, about half of all patients had all three
risk factors controlled (Figure 1). Documentation of all
three risk factors was higher in obesity than in overweight
or normal weight (p < 0.0001), but control of all three risk
factors was lower, (p < 0.0001), with only 44% of patients
with obesity having all risk factors under control.
Table 1: Body Mass Index Documentation in 79,947 Patients in 12 Primary Care Clinics
Clinic N BMI Height Documented Weight Documented
%% %
1 3,027 93.5 94.1 99.1
2 4,559 89.8 95.7 91.6
3 3,274 86.9 87.5 99.1
4 3,989 85.8 94.5 87.4
5 1,344 75.1 75.2 99.5
6 7,747 65.8 66.0 99.0
7 21,299 64.0 65.8 96.1
8 3,962 55.4 55.8 98.7
9 12,919 50.2 55.4 71.1
10 4,781 41.9 44.4 78.4
11 8,052 38.2 38.3 99.0
12 4,994 34.0 35.7 88.9
Total 48,376 60.5 63.0 90.9
Data are ranked by BMI documentation rate, include patients at least 18 years of age with at least two clinic visits billed to their PCP between 7/1/
05 and 12/31/06, and include underweight patients (BMI <18.5 kg/m2) excluded from the main analysis. BMI = Body Mass Index (weight in kilograms/
height in meters2)BMC Health Services Research 2009, 9:236 http://www.biomedcentral.com/1472-6963/9/236
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Table 2: Patient Demographics and Clinical Characteristics in 79,947 Patients in 12 Primary Care Clinics by Documentation or 
Missingness of BMI
Characteristic BMI Documented 48,376 BMI not Documented 31,571 P value
Clinic n % <0.0001
1 2,830 5.9 197 0.6
2 4,093 8.5 466 1.5
3 2,844 5.9 430 1.4
4 3,421 7.1 568 1.8
5 1,009 2.1 335 1.1
6 5,095 10.5 2,652 8.4
7 13,630 28.2 7,669 24.3
8 2,194 4.5 1,768 5.6
9 6,489 13.4 6,431 20.4
10 2,003 4.1 2,778 8.8
11 3,073 6.4 4,979 15.8
12 1,696 3.5 3,298 10.5
Age mean years 51 53 <0.0001
Women n % 31,412 64.9 15,986 50.6 <0.0001
Race n % <0.0001
White 37,625 77.8 25,264 80.0
Asian 2,057 4.3 1,426 4.5
Black 2,908 6.0 1,464 4.6
Hispanic 4,123 8.5 2,397 7.6
Number of PCP visits mean range 4.2 (2-61) 3.9 (2-56) <0.0001
Commercial Insurance or Medicare n % 42,740 88.4 27,522 87.2 <0.0001
History of CVD n % 7,298 15.1 4,989 15.8 0.0060
History of diabetes n % 5,872 12.1 3,453 10.9 <0.0001
History of hypertension n % 22,121 45.7 14,698 46.6 0.02
History of dyslipidemia n % 25,698 53.1 17,133 54.3 0.002
HbA1c % 6.7 6.8 0.0001
Blood pressure mean mmHg 122/75 123/74 <0.0001
Total cholesterol mean mg/dL (mmol/L) 188.1 (4.87) 188.5 (4.88) 0.29
LDL mean mg/dL (mmol/L) 104.1 (2.70) 105 (2.72) 0.001
HDL mean mg/dL (mmol/L) 59.3 (1.54) 57.8 (1.50) <0.0001
Triglyceride level mean mg/dL (mmol/L) 127.8 (1.44) 132.6 (1.50) <0.0001
Casual glucose mean mg/dL (mmol/L) 101.8 (5.65) 100.8 (5.59) 0.0007
Fasting glucose mean mg/dL (mmol/L) 102.4 (5.68) 100.9 (5.60) 0.0007
Risk factor documentation Total n %
Blood Pressure 64,204 80.3 37,489 77.5 26,715 84.6 <0.0001
LDL 55,210 69.1 33,788 69.8 21,422 67.9 <0.0001
Casual glucose 56,984 71.3 35,125 72.6 21,859 69.2 <0.0001
Fasting glucose 21,533 26.9 13,533 28.0 8,000 25.3 <0.0001
HbA1c 14,252 17.8 9,367 19.4 4,885 15.5 <0.0001
Total cholesterol 58,951 73.7 36,247 74.9 22,704 71.9 <0.0001
HDL 58,373 73.0 35,874 74.2 22,499 71.3 <0.0001
Triglycerides 55,948 70.0 34,247 70.8 21,701 68.7 <0.0001
Risk factor control in those with 
documented risk factor
Total n %
Blood Pressure <130 and < 85 
mmHg
46,748 72.8 27,212 72.6 19,536 73.1 0.13
LDL <130 mg/dL 43,369 78.6 26,656 78.9 16,713 78.0 0.015
Casual glucose < 200 mg/dL 55,642 97.6 34,231 97.5 21,411 98.0 0.0001
Fasting glucose < 100 mg/dL 13,782 64.0 8,574 63.4 5,208 65.1 0.01
HbA1c <7% 9,638 67.6 6,463 69.0 3,175 65.0 <0.0001
Total cholesterol <200 mg/dL 37,279 63.2 22,952 63.3 14,327 63.1 0.59
HDL >35 mg/dL (male) and >40 
mg/dL (female)
52,971 90.8 32,742 91.3 20,229 89.9 <0.0001
Triglycerides <150 mg/dL 48,188 86.1 29,675 86.7 18,513 85.3 <0.0001
P-value compares BMI documented with BMI not documented. BMI = Body Mass Index (weight in kilograms/height in meters2), PCP = Primary Care 
Physician, CVD = Cardiovascular Disease, HbA1c = Hemoglobin A1C, LDL=low density lipoprotein cholesterol, HDL = high density lipoprotein 
cholesterol. LDL <130 mg/dL = <3.367 mmol/L; casual glucose <200 mg/dL = <5.55 mmol/L; fasting glucose <100 mg/dL = <11.1 mmol/LBMC Health Services Research 2009, 9:236 http://www.biomedcentral.com/1472-6963/9/236
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The presence of CVD or diabetes modified some associa-
tions of BMI category with risk factor documentation and
control. In patients with CVD or diabetes, the rates of doc-
umentation were generally less different comparing
patients with obesity with those of normal weight, while
in patients without CVD or diabetes, rates of documenta-
tion were strikingly higher in patients with obesity than
normal weight (Figure 1, Table 5, p = 0.26 to <0.0001 for
CVD- or diabetes-by-BMI category interaction). Likewise,
in patients with CVD or diabetes the rates of control were
generally less different comparing patients with obesity
with those with normal weight, but in patients without
CVD or diabetes, rates of control were strikingly lower in
patients with obesity than normal weight (Figure 1, Table
6). Overall 50% or fewer of the patients with obesity and
CVD or diabetes had all three risk factors under control
(Figure 1, Tables 5 and 6).
Discussion
We examined the current state of BMI documentation and
documentation and control of associated risk factors by
BMI category, based on EHR data from almost 80,000
adult patients seen in a 12-clinic primary care network
during 18 months in 2005-2006. Our findings demon-
strate variations in risk factor recognition and control for
obese persons compared to those of normal weight, as
well as for those with and without CVD or type 2 diabetes.
We found that documentation of BMI varied widely by
clinic site and was overall low. Among patients with a BMI
recorded, documentation of most risk factors was higher
in patients with obesity compared with normal weight
patients; however, control of risk factors was poorer in
obesity than normal weight. Patients without a docu-
mented history of CVD or diabetes had strikingly more
dissimilar rates of documentation and control between
weight categories than patients with CVD or diabetes.
Overall, patients with obesity with or without CVD or dia-
betes had lower rates of risk factor documentation and
control than may be ideal given their high absolute risk of
adverse health outcomes.
Our study builds upon findings from previous studies.
Lemay  et al audited medical records from 465 adult
patients seen at a community health center during one
week in February of 1999 to evaluate height and weight
documentation and obesity diagnosis by the practitioner
over a prior six-month period, and found that only 63%
of their patient cohort had a height and weight docu-
mented [27]. Similar to our study, Lemay looked a group
of patients in normal clinical practice; however, we were
able to expand upon this study in terms of a far larger
study sample as well as a longer sampling frame to assess
provision of services (18 months versus 6 months),
potentially providing a more accurate picture of risk factor
evaluation. Six years after this study and seven years after
the establishment of the NHLBI guidelines, we found the
percentage of BMI documentation to be essentially the
same (63% versus 60.5%). Rifas-Shiman et al studied
5,025 members of the same insurance plan and group
practice who were a subset of participants from a cohort
study and were continuously enrolled since 1999, had a
visit in 2000, had a BMI measurement between January 1,
2000 and December 31, 2000, and who did not have
medical conditions related to weight loss or CVD. They
found that higher BMI was an independent predictor of
increased fasting glucose, triglyceride, LDL cholesterol,
and HDL cholesterol screening [28]. Rifas-Shiman identi-
fied lipid and glucose abnormalities over a two-year
period, comparable in time to our study. Neither we nor
Rifas-Shiman could evaluate attempts at management, so
reasons for increased documentation such as guideline
adherence could not be assessed. Our analysis extends
prior studies by evaluating whether those with documen-
tation of risk factors had those risk factors in control
Table 3: Characteristics of 47,628 Primary Care Patients by BMI Category
Characteristic Obese n = 14,290 Overweight n = 16,402 Normal n = 16,936 P value
Age (mean years) 53 53 48 <0.0001
Number of PCP visits (mean) 4.7 4.2 3.9 <0.0001
Women n (%) 8,565 59.9 8,899 54.3 13,272 78.4 <0.0001
Race* n (%) <0.0001
White 10,712 75.0 12,674 77.3 13,655 80.6
Asian 179 1.3 567 3.5 1,229 7.3
Black 1,244 8.7 989 6.0 649 3.8
Hispanic 1,722 12.1 1,561 9.5 811 4.8
Private Insurance or Medicare n (%) 12,104 84.7 14,502 88.4 15,467 91.3 <0.0001
History of CVD n (%) 2,647 18.5 2,699 16.5 1,862 11.0 <0.0001
History of diabetes n (%) 3,238 22.7 1,789 10.9 824 4.9 <0.0001
History of hypertension n (%) 9,116 63.8 7,895 48.1 4,931 29.1 <0.0001
History of dyslipidemia n (%) 9,235 64.6 9,495 57.9 6,769 40.0 <0.0001
P-value is for general association across BMI categories. BMI = Body Mass Index (weight in kilograms/height in meters2), PCP = Primary Care 
Physician, and CVD = Cardiovascular Disease. *Designation "Other" for race deleted from set.BMC Health Services Research 2009, 9:236 http://www.biomedcentral.com/1472-6963/9/236
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according to Adult Treatment Panel III (ATP III) metabolic
syndrome guidelines for a patient with average cardiovas-
cular risk.
Molenaar et al studied rates of treatment and control of
hypercholesterolemia, hypertension, and diabetes in nor-
mal weight, overweight, and obese subjects with a history
of these conditions utilizing a CVD-free subset of the
Framingham Heart Study. They found that subjects with
hypercholesterolemia and hypertension who were obese
were more likely to have these conditions treated than
normal weight subjects. Rates of control of hypertension
and hypercholesterolemia were uniformly poor and did
not differ between weight groups. Rates of control of dia-
betes were poor among all three weight groups, but sub-
jects who were obese were less likely to have control of
fasting blood glucose than normal weight subjects. The
goal of our study, however, was different from that of
Molenaar. Molenaar studied rates of treatment and con-
trol of hypercholesterolemia, hypertension, and diabetes
in normal weight, overweight, and obese subjects with a
history of these conditions who were free of CVD, a sub-
group of patients with a clear indication for BMI screen-
ing. Our goal was to evaluate in all patients, both with and
without obesity-associated risk factors, the current state of
BMI screening and subsequent screening for associated
risk factors by BMI group, according to HEDIS and NHLBI
guidelines. Molenaar et al examined a well-known, stand-
ardized study population, where only 196 subjects had
missing BMI data. Our population was a non-standard-
ized data source, and our subjects were a mixture of both
those with and without CVD and its risk factors, with fur-
ther subanalysis in patients with a history of CVD and dia-
betes. Despite these differences, findings from the
structured Framingham population and from our analysis
of usual clinical care are strikingly similar. This minimizes
to a large degree the concern that high rates of missing
BMI information could have distorted our findings, and
may explain why our percentages of control were higher
than those found by Molenaar, albeit still low overall
[29].
The rapidly growing prevalence of obesity has pushed BMI
assessment to appropriate prominence as a newly pro-
posed reportable HEDIS measure. BMI assessment will be
made by several means, including survey of EHRs in
health care networks. Our results suggest that the HEDIS
BMI Assessment measure has potential to provide a timely
quality and safety foundation to improve care for patients
with obesity. At least in our large primary care network,
there clearly is substantial room for improvement in doc-
umentation of BMI and documentation and control of
BMI-associated risk factors. While height and weight and
BMI documentation may reflect individual physician
practice styles, by speaking with medical directors we
found that lack of height and weight appeared to be a
clinic-level and not an individual PCP issue, with height
and weight recording often performed or not performed
before the PCP sees the patient. It is expected that intro-
duction of the HEDIS BMI Assessment measure will
improve this state of affairs, although the effectiveness of
BMI documentation alone to improve care remains to be
demonstrated.
According to our study, patients with already documented
CVD or diabetes are more likely to have risk factor docu-
mentation and control regardless of BMI category. Those
without a documented history of CVD or diabetes demon-
Table 4: Documentation and Control of Risk Factors among 47,628 Primary Care Patients, by BMI Category
Risk Factor Documentation Total n = 47,628 Obese n = 14,290 Overweight n = 16,402 Normal n = 16,936 P value
n%n% n % n %
BP 36,934 77.6 10,900 76.3 12,890 78.6 13,144 77.6 <0.0001
LDL 33,427 70.2 11,239 78.7 12,013 73.2 10,175 60.1 <0.0001
Casual Glucose 34,589 72.6 11,216 78.5 11,901 72.6 11,472 67.7 <0.0001
Fasting Glucose 13,421 28.2 5,347 37.4 4,804 29.3 3,270 19.3 <0.0001
Risk Factor Control Total Obese Overweight Normal P value
n%n% n % n %
BP <130 and < 85 mmHg 26,736 72.4 6,801 62.4 9,202 71.4 10,733 81.7 <0.0001
LDL <130 mg/dL 26,328 78.8 8,777 78.1 9,273 77.2 8,278 81.4 <0.0001
Casual glucose < 200 mg/dL 33,698 97.4 10,707 95.5 11,635 97.8 11,356 99.0 <0.0001
Fasting glucose < 100 mg/dL 8,482 63.2 2,753 51.5 3,146 65.5 2,583 79.0 <0.0001
P-value is for general association across BMI categories. BMI=Body Mass Index (weight in kilograms/height in meters²); LDL <130 mg/dL=<3.367 
mmol/L; casual glucose <200 mg/dL=<5.55 mmol/L; fasting glucose <100 mg/dL=<11.1 mmol/L.BMC Health Services Research 2009, 9:236 http://www.biomedcentral.com/1472-6963/9/236
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Documentation and control of all three risk factors by BMI category Figure 1
Documentation and control of all three risk factors by BMI category. A. Documentation of all 3 risk factors by BMI 
category; B. Documentation of all 3 risk factors by BMI category, stratified by history of CVD; C. Documentation of all 3 risk 
factors by BMI category, stratified by history of diabetes. D. Control of all 3 risk factors by BMI category; E. Control of all 3 risk 
factors by BMI category, stratified by history of CVD; F. Control of all 3 risk factors by BMI category, stratified by history of 
diabetes.
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Table 5: Documentation of Risk Factors in 47,628 Patients in 12 Primary Care Clinics Stratified by BMI Category and History of CVD 
or Diabetes
Risk Factors Total Obese n = 14,290 Overweight n = 16,402 Normal 
Weight
n = 16,936 P value
History of 
CVD
n% n % n % n %
H/O CVD n 
= 7,208
H/O CVD N = 2,647 H/O CVD N = 2,699 H/O CVD N = 1,862
NO H/O 
CVD n = 
40,420
No H/O CVD N = 11,643 NO H/O CVD N = 13,703 NO H/O CVD N = 15,074
BP n = 10,900 n = 12,890 n = 13,144
H/O CVD 5,297 73.5 1,931 73.0 1,991 73.8 1,375 73.9 0.26
NO H/O 
CVD
31,637 78.3 8,969 77.0 10,899 79.5 11,769 78.1
LDL n = 11,239 n = 12,013 n = 10,175
H/O CVD 6,199 86.0 2,393 90.4 2,358 87.4 1,448 77.8 0.15
NO H/O 
CVD
27,228 67.4 8,846 76.0 9,655 70.5 8,727 57.9
Casual glucose n = 11,216 n = 11,901 n = 11,472
H/O CVD 6,305 87.5 2,355 89.0 2,322 86.0 1,628 87.4 0.0001
NO H/O 
CVD
28,284 70.0 8,861 76.1 9,579 69.9 9,844 65.3
Fasting 
glucose
n = 5,347 n = 4,804 n = 3,270
H/O CVD 2,741 38.0 1,158 43.8 1,023 37.9 560 30.1 <0.0001
NO H/O 
CVD
10,680 26.4 4,189 36.0 3,781 27.6 2,710 18.0
All 3 risk 
factors
n = 8,247 n = 8,797 n = 6,986
H/O CVD 4,417 61.3 1,696 64.1 1,693 62.7 1,028 55.2 <0.0001
NO H/O 
CVD
19,613 48.5 6,551 56.3 7,104 51.8 5,958 39.5
History of DM n% n % n %
H/O 
diabetes n = 
5,851
H/O diabetes N = 3,238 H/O diabetes N = 1,789 H/O diabetes N = 824
NO H/O 
diabetes
n = 41,777
NO H/O diabetes N = 
11,052
NO H/O diabetes N = 14,613 NO H/O diabetes N = 
16,112
BP n = 10,900 n = 12,890 n = 13,144
H/O 
diabetes
4,398 75.2 2,447 75.6 1,366 76.4 585 71.0 0.002
NO H/O 
diabetes
32,536 77.9 8,453 76.5 11,524 78.9 12,559 78.0
LDL n = 11,239 n = 12,013 n = 10,175
H/O 
diabetes
5,285 90.3 2,963 91.5 1,617 90.4 705 86.2 0.51
NO H/O 
diabetes
28,142 67.4 8,276 74.9 10,396 71.1 9,470 58.8
Casual glucose n = 11,216 n = 11,901 n = 11,472
H/O 
diabetes
5,225 89.3 2,884 89.1 1,596 89.2 745 90.4 <0.0001
NO H/O 
diabetes
29,634 70.9 8,332 75.4 10,305 70.5 10,727 66.6
Fasting 
glucose
n = 5,347 n = 4,804 n = 3,270BMC Health Services Research 2009, 9:236 http://www.biomedcentral.com/1472-6963/9/236
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strated more variation in risk factor documentation and
control by BMI category. At least two recent studies cor-
roborate these data. Melamed et al measured BMI in 289
patients in seven family practice clinics in Israel, and
found that BMI was documented in only half of obese
patients and 39% of overweight patients, and that patients
with other chronic medical conditions were more likely to
have BMI documented than those without documented
comorbidities [30]. Waring et al looked at 2,330 over-
weight and obese patients included in the Cholesterol
Education and Research Trial, and found increased odds
of overweight or obesity management in relation to
weight-related comorbidities for those with moderate or
severe obesity [31].
Risk factor control appears to be related to a previously
diagnosed risk factor and not to obesity. These findings
become even more relevant in light of recent studies that
demonstrate increased CVD risk in patients who are over-
weight and obese compared to normal weight patients,
independent of hypertension and hypercholesterolemia
[32]. This implies an important need to recognize over-
weight and obesity, ideally using a simple technique such
as BMI, in order to enhance CVD and diabetes complica-
tions prevention. Our findings suggest that PCPs are
aware of CVD, diabetes, and obesity as strongly tied risk
factors, but that they may not recognize obesity as a risk
factor for morbidity and mortality independent of these
other comorbidities.
Limitations
Our results must be interpreted with some limitations in
mind. This is clinical, not research, data, which naturally
suffers from information that is missing and inconsistent
in its recording. We carefully addressed missingness with
multiple methods of ascertaining exposures, and
addressed inconsistencies in data recording by removal of
clinically illogical extreme outliers. Evaluation of BMI
documentation rates, with the inherent missing data, was
a goal of our study. Furthermore, despite its limitations,
evaluation of clinical data is a strength of this study, in
that it provides a glimpse into current obesity care and
insights into improving this practice. Although our data
were derived from a single academic health care network,
the sites included a representative mixture of urban, sub-
urban, and hospital-based practices, making our findings
generalizable and potentially replicable. Another impor-
tant strength of our study is the use of a long-standing,
widely used EHR encompassing all aspects of patient care
from a large network of diverse clinics and patient popu-
lations. EHRs, while not a perfect tool due to the potential
for improperly entered or overlooked data, have great
potential for research, with studies showing that EHRs
have potential for increasing documentation and treat-
ment of obese patients [33]. Finally while there were dif-
ferences seen in the percentages of documentation of risk
factors, this may be due mainly to test indication, whereby
certain tests such as cholesterol levels are more likely to be
ordered on most patients than fasting glucose. However,
our overall documentation numbers were large enough to
yield consistent results across BMI categories.
Conclusions
It is well-accepted that intentional weight loss mitigates
many of the risk factors associated with obesity. Despite
rising rates of obesity, physicians appear not to routinely
assess BMI during office visits [34]. According to the
NCQA, multiple organizations recommend measuring
BMI as part of the routine physical examination
[16,9,10,14,15]. Treatment recommendations for obesity
depend on ascertainment of BMI and complications of
obesity. Therefore, screening for BMI and comorbidities
could change patient management. In light of new studies
implicating overweight and obesity as independent risk
factors for CVD, recognition of BMI becomes even more
important in the primary care setting. We examined a
large, diverse primary care network to evaluate current
care and found that EHRs will be a useful tool to evaluate
H/O 
diabetes
2,736 46.8 1,619 50.0 812 45.4 305 37.0 0.003
NO H/O 
diabetes
10,685 25.6 3,728 33.7 3,992 27.3 2,965 18.4
All 3 risk 
factors
n = 8,247 n = 8,797 n = 6,986
H/O 
diabetes
3,936 67.3 2,197 67.9 1,240 69.3 499 60.6 0.001
NO H/O 
diabetes
20,094 48.1 6,050 54.7 7,557 51.7 6,487 40.3
P-value compares homogeneity of odds ratios across groups. CVD = Cardiovascular Disease, BMI = Body Mass Index (weight in kilograms/height in 
meters2), BP = Blood Pressure, LDL = low density lipoprotein cholesterol, HDL = high density lipoprotein cholesterol. All 3 risk factors 
documented = documentation of BP + LDL + casual OR fasting glucose. Numbers and percentages in table reflect percentage of risk factor 
documented by BMI type in patients either with or without a history of CVD or DM (i.e., 1,931 = 73% of 2,647 patients who are obese with BP 
documented with a history of CVD).
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Table 6: Control of Risk Factors in 47,628 Patients in 12 Primary Care Clinics Stratified by BMI Category and History of CVD or Diabetes
Outcome Total 
Documented
Total Controlled Obese Overweight Normal P value
History of CVD n % n % n % n % n %
H/O CVD n = 7,208
NO H/O CVD
n = 40,420
BP < 130 and < 85 
mmHg
H/O CVD N = 1,931 H/O CVD N = 1,991 H/O CVD N = 1,375
NO H/O CVD 8,969 NO H/O CVD N = 10,899 NO H/O CVD N = 11,769
n = 6,801 n = 9,202 n = 10,733
H/O CVD 5,297 73.5 3,338 63.0 1,155 59.8 1,256 63.1 927 67.4 <0.0001
NO H/O CVD 31,637 78.3 23,399 74.0 5,647 63.0 7,946 72.9 9,806 83.3
LDL < 130 md/dL H/O CVD N = 2,393 H/O CVD N = 2,358 H/O CVD N = 1,448
NO H/O CVD N = 8,846 NO H/O CVD N = 9,655 NO H/O CVD N = 6,989
n = 8,777 n = 9,273 n = 8,278
H/O CVD 6,199 86.0 5,515 89.0 2,152 89.9 2,074 88.0 1,289 89.0 0.002
NO H/O CVD 27,228 67.4 20,813 76.4 6,625 74.9 7,199 74.6 6,989 80.1
Casual glucose < 200 
mg/dL
H/O CVD N = 2,355 H/O CVD N = 2,322 H/O CVD N = 1,628
NO H/O CVD N = 8,861 NO H/O CVD N = 9,579 NO H/O CVD N = 9,844
n = 10,707 n = 11,635 n = 11,356
H/O CVD 6,305 87.5 5,979 94.8 2,173 92.3 2,218 95.5 1,588 97.5 0.13
NO H/O CVD 28,284 70.0 27,719 98.0 8,534 96.3 9,417 98.3 9,768 99.2
Fasting glucose < 100 
mg/dL
H/O CVD N = 1,158 H/O CVD N = 1,023 H/O CVD N = 560
NO H/O CVD N = 4,189 NO H/O CVD N = 3,781 NO H/O CVD N = 2,710
n = 2,753 n = 3,146 n = 2,583
H/O CVD 2,741 38.0 1,325 48.3 415 35.8 561 54.8 349 62.3 0.0005
NO H/O CVD 10,680 26.4 7,157 67.0 2,338 55.8 2,585 68.4 2,234 82.4
All 3 risk factors H/O CVD N = 829 H/O CVD N = 1,693 H/O CVD N = 1,028
NO H/O CVD N = 2,767 NO H/O CVD N = 7,104 NO H/O CVD N = 5,958
n = 3,596 n = 4,344 n = 4,327
H/O CVD 4,417 61.3 2,252 51.0 829 48.9 850 50.2 573 55.7 <0.0001
NO H/O CVD 19,613 48.5 10,015 51.1 2,767 42.2 3,494 49.2 3,754 63.0B
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History of diabetes
H/O diabetes n = 
5,851
NO H/O diabetes n = 
41,777
BP < 130 and < 85 
mmHg
H/O diabetes N = 2,447 H/O diabetes N = 1,366 H/O diabetes N = 585
NO H/O diabetes 8,453 NO H/O diabetes N = 11,524 NO H/O diabetes N = 12,559
n = 6,801 n = 9,202 n = 10,733
H/O diabetes 4,398 75.2 2,775 63.1 1,476 60.3 919 67.3 380 65.0 <0.0001
NO H/O diabetes 32,536 77.9 23,961 73.6 5,325 63.0 8,283 71.9 10,353 82
LDL < 130 md/dL H/O diabetes N = 2,963 H/O diabetes N = 1,617 H/O diabetes N = 705
NO H/O diabetes N = 8,276 NO H/O diabetes N = 10,396 NO H/O diabetes N = 9,470
n = 8,777 n = 9,273 n = 8,278
H/O diabetes 5,285 90.3 4,746 89.8 2,635 88.9 1,462 90.4 649 92.1 0.57
NO H/O diabetes 28,142 67.4 21,583 76.7 6,143 74.2 7,811 75.1 7,629 80.6
Casual glucose < 200 
mg/dL
H/O diabetes N = 2,884 H/O diabetes N = 1,596 H/O diabetes N = 745
NO H/O diabetes N = 8,332 NO H/O diabetes N = 10,305 NO H/O diabetes N = 10,727
n = 10,707 n = 11,635 n = 11,356
H/O diabetes 5,225 89.3 4,383 83.9 2,400 83.2 1,342 84.1 641 86.0 0.015
NO H/O diabetes 29,634 70.9 29,315 98.9 8,307 99.7 10,293 99.9 10,715 99.9
Fasting glucose < 100 
mg/dL
H/O diabetes N = 
1,619
H/O diabetes N = 812 H/O diabetes N = 
305
0.24
NO H/O diabetes N = 
3,728
NO H/O diabetes N = 
3,992
NO H/O diabetes 
2,965
n = 2,753 n = 3,146 n = 2,583
H/O diabetes 2,736 46.8 554 20.2 285 17.6 170 20.9 99 32.5
NO H/O diabetes 10,685 25.6 7,928 74.2 2,468 66.2 2,976 74.6 2,484 83.8
All 3 risk factors H/O diabetes N = 2,197 H/O diabetes N = 1,240 H/O diabetes N = 499 <0.0001
NO H/O diabetes N = 6,050 NO H/O diabetes N = 7,557 NO H/O diabetes N = 6,487
n = 3,596 n = 4,344 n = 4,327
H/O diabetes 3,936 67.3 1,754 44.6 929 42.3 587 47.3 238 47.7
NO H/O diabetes 20,094 48.1 10,513 52.3 2,667 44.1 3,757 49.7 4,089 63.0
P-value compares homogeneity of the odds ratios across groups. CVD = Cardiovascular Disease, BMI = Body Mass Index (weight in kilograms/height in meters2), BP = Blood Pressure, LDL = Low 
density lipoprotein cholesterol, HDL = High density lipoprotein cholesterol. Risk factor control rates are from patients with risk factors documented. Numbers and percentages in table reflect 
percentage of risk factor documented by BMI type in patients either with or without a history of CVD or DM (i.e., 1,931 = 73% of 2,647 patients who are obese with BP documented with a history 
of CVD). All 3 risk factors controlled = control of BP + LDL + casual OR fasting glucose. Documentation or control of all 3 risk factors defined as BP, LDL, and fasting or casual glucose below the 
thresholds indicated.
Table 6: Control of Risk Factors in 47,628 Patients in 12 Primary Care Clinics Stratified by BMI Category and History of CVD or Diabetes (Continued)BMC Health Services Research 2009, 9:236 http://www.biomedcentral.com/1472-6963/9/236
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BMI assessment. We demonstrate substantial opportuni-
ties for improvement in the assessment and control of adi-
posity and associated risk factors that are needed to
address the US obesity epidemic.
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